Erytech Pharma S.A. (ERYP) Social Stream
ERYTECH PHARMA SA (ERYP) Price Targets From Analysts
Use the tables below to see what analysts covering ERYTECH PHARMA SA think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-02 | 2 | $3.2 | $3.2 | $3.2 | $0.78 | 310.26% |
| NA | 1 | $NA | $NA | $NA | $0.78 | NA% |
The Trend in the Analyst Price Target
ERYP's average price target has moved down $18.59 over the prior 17 months.
500 - Internal server error
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|
ERYP Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 3 | 0 | 0 | 2 | 0 | 0 | 2 |
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ERYP as an investment opportunity.
- In the context of all US stocks, ERYTECH PHARMA SA's number of analysts covering the stock is higher than 3.2% of them.
- ERYTECH PHARMA SA's variance in analysts' estimates is lower than almost 100% of all US stocks.
- In the context of Pharmaceutical Products stocks, ERYTECH PHARMA SA's average analyst price target is higher than 3.37% of them.
- ERYP has a greater upside potential (average analyst target price relative to current price) than 75.06% of stocks in the small market cap category.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to ERYTECH PHARMA SA are SLDB, XFOR, and APTO.
View All Top Stocks by Price Target
Make investment decisions regarding ERYP using the data that counts. Try POWR Ratings for free.